Stages two and three of the tumors had increased transcript expression of BIRC5 significantly compared to normal, as well as stages one and four of the tumors, and BIRC5 remained overexpressed (p < 0.001) throughout tumor stages (Figure 3c). The gene discussed is BIRC5; the disease is neoplasm.